Autoimmune Disease Diagnosis Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029
Overview
Autoimmune Disease Diagnosis Market is expected to grow at a CAGR of 8% during the forecast period. Autoimmune Disease Diagnosis Market is expected to reach US$ 8.18 Bn. by 2029.
No single test can diagnose most autoimmune diseases; many doctors use a combination of tests and a review of symptoms and physical examination to diagnose patients. The antinuclear antibody test (ANA) is often one of the first tests that doctors use when symptoms suggest an autoimmune disease.
Autoimmune diseases are relatively common for instance, more than 23.5 million people in the United States have at least one autoimmune condition. They are a leading cause of death and disability. This factor is increasing the need for the autoimmune disease diagnosis market.
To know about the Research Methodology :- Request Free Sample Report
Autoimmune Disease Diagnosis Market Dynamics:
Autoimmune Disease Diagnosis Market to be driven by Rising Occurrence of Infectious Diseases
The market for Autoimmune Disease Diagnosis is showing a Northward trend. Epidemic outbreaks of infectious pathogens resulting in a rise in demand for Autoimmune Disease Diagnosis. The market is growing thanks to rising awareness of autoimmune diseases, a high prevalence of autoimmune diseases, and comprehensive research on autoimmune diseases.
Innovative research methods that provide results in a short amount of time, as well as the advent of new market players with novel technology, high precision, and ease of use, are posing a challenge to the Autoimmune Disease Diagnosis market's growth and posing a tough challenge to well-established key players. Initiatives to raise awareness about antimicrobial resistance and how to counter it has created many lucrative opportunities for the key players operating in this market.
The market's growth has been fueled by the government's comprehensive research and development programs for treatment methods, which are specifically aimed at developing superior diagnosis. According to the International Diabetes Federation's 2017 (IDF) estimate, the global diabetes population could reach 629 million by 2045, with approximately 425 million adults (20-79 years) suffering from the disease in 2017.
The report has profiled twenty five key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. The manufacturing environment in each region is different and focus is given on the regional impact on the cost of manufacturing, supply chain, availability of raw materials, labor cost, availability of advanced technology, trusted vendors are analysis and report has come up with recommendations for a future hot spot in the North America. Major country’s policies about manufacturing and their impact on Autoimmune Disease Diagnosis demand are covered in the report.
Autoimmune Disease Diagnosis Market Segment Analysis
The consumables & assay kits segment is expected grow at a CAGR of 8% during the forecast period.
Based on the product, in 20, the consumables & assay kits products segment holds the largest market share of xx% in 2022 and it is estimated to reach USD$ xx Mn by 2029. The rising occurrence of autoimmune disease, as well as the growing number of product launches/approvals, have boosted market growth. With the development and identification of SARCS - CoV 2 and Covid – 19 pandemic has increased the need for the consumable & assay kit market. In addition, the rising number of autoimmune diseases and increasing number of product launches and government approvals are supporting the market growth.
Autoimmune Disease Diagnosis Market Regional Insights:
Europe to witness high market growth rate and is expected to grow at a CAGR of 8% by 2029
The Europe market for Autoimmune Disease Diagnosis is expected to rise at a faster pace than the rest of the world by 2029. The main factors driving market growth in North America are growing prevalence of infectious diseases, increased R&D to build novel automated AST systems, technological advances, and safety concerns. Increased geriatric population and chronic disease incidences are two major factors driving the autoimmune disease diagnosis industry's development in Europe. Furthermore, most of the world's leading corporations, such as Grifols, EUROIMMUN AG, Trinity Biotech, Werfen, and Oncimmune headquartered in the area or have a significant presence there. Others have concentrated on growth in order to broaden their scope and capabilities. Another important factor contributing to the market's rapid expansion is this factor.
The objective of the report is to present a comprehensive analysis of the global Autoimmune Disease Diagnosis market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the global Autoimmune Disease Diagnosis market dynamics, structure by analyzing the market segments and project the global Autoimmune Disease Diagnosis market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Autoimmune Disease Diagnosis market make the report investor’s guide.
Covid-19 Impact:
COVID-19 Impact on the global Autoimmune Disease Diagnosis market
The governments of all Covid-19-affected countries are most concerned about testing large numbers of patients for potential Sars-Cov-2 infection. As a result, the majority of them are experiencing severe shortages of testing kits to screen for the virus. Labs in a number of countries are requesting more in-vitro or point-of-care testing capabilities, and Diagnostics virology entities are under tremendous pressure to provide accurate testing kits.
Autoimmune Disease Diagnosis Market Scope: Inquire before buying
| Autoimmune Disease Diagnosis Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2017 to 2022 | Market Size in 2022: | US $ 4.77 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 8% | Market Size in 2029: | US $ 8.18 Bn. |
| Segments Covered: | by Product | • Consumables & Assay Kits • Instruments |
|
| by Test Type | • Routine Laboratory Tests • Inflammatory Markers • Autoantibodies & Immunologic Test • Other Tests |
||
| by Disease | • Rheumatoid Arthritis • Systemic Lupus Erythematosus • Sjogren’s Syndrome • Thyroiditis • Scleroderma • Other Diseases |
||
| by End-User | • Clinical Laboratories • Hospitals • Other End Users |
||
Autoimmune Disease Diagnosis Market, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Autoimmune Disease Diagnosis Market Key Players
• Thermo Fisher Scientific
• Siemens
• Abbott
• Danaher
• Bio-Rad Laboratories
• Grifols
• Trinity Biotech
• Werfen
• HYCOR Biomedical
• EUROIMMUN AG
• Oncimmune
• HTG Molecular Diagnostics
• Seramun Diagnostica GmbH
• Exagen Inc.
• Cambridge Life Sciences Limited
• A. Menarini Diagnostics s.r.l
• ORGENTEC Diagnostika
• KRONUS
• AESKU GROUP GMBH & CO. KG
• Other key players
Frequently Asked Questions:
1. Which region has the largest share in Global Autoimmune Disease Diagnosis Market?
Ans: Europe region held the highest share in 2022.
2. What is the growth rate of Global Autoimmune Disease Diagnosis Market?
Ans: The Global Autoimmune Disease Diagnosis Market is growing at a CAGR of 8% during forecasting period 2023-2029.
3. What is scope of the Global Autoimmune Disease Diagnosis Market report?
Ans: Global Autoimmune Disease Diagnosis Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Autoimmune Disease Diagnosis Market?
Ans: The important key players in the Global Autoimmune Disease Diagnosis Market are – Thermo Fisher Scientific, Siemens, Abbott, Danaher, Bio-Rad Laboratories, Grifols, Trinity Biotech, Werfen, HYCOR Biomedical, EUROIMMUN AG, Oncimmune, HTG Molecular Diagnostics, Seramun Diagnostica GmbH, Exagen Inc., Cambridge Life Sciences Limited, A. Menarini Diagnostics s.r.l, ORGENTEC Diagnostika, KRONUS, AESKU GROUP GMBH & CO. KG, Other key players
5. What is the study period of this Market?
Ans: The Global Autoimmune Disease Diagnosis Market is studied from 2022 to 2029.